Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Exelixis Eyes Liver Cancer OK To Help Drive Cabometyx Sales
Mar 16 2018
•
By
Kevin Grogan
CELESTIAL data could get Exelixis another approval for Cabometyx • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Anticancer
More from Therapeutic Category